American authorities have given green light to the experimental drug Remdesivir on Friday, May 1, for emergency use on seriously ill COVID-19 patients, after a major trial found that it boosted their recovery. Remdesivir, an antiviral drug, was given the green light in serious COVID-19 patients. The approval of the drug initially developed to treat Ebola by US regulators is the latest step in a global push towards finding viable treatments and a vaccine for the COVID-19, which has subjected the entire world in severe affliction.

Nigeria has on Sunday recorded 91 additional cases of Coronavirus (COVID-19), making the total number of confirmed cases to 1273, the Nigeria Centre for Disease Control (NCDC) said. According to a tweet by the NCDC, 43 cases were recorded in Lagos State, 8 in Sokoto, 6 in Taraba, and 5 in Kaduna and Gombe.

Following the concept of “immunity passports” or “risk-free certificates” which argues that individuals can only contract the Coronavirus once, being peddled as a way of allowing people protected against reinfection to return to work, the World Health Organization, WHO has recanted against the unproven theory as well as proposals for reopening society that is based on this supposed immunity.